Skip to search formSkip to main contentSkip to account menu

YM 461

Known as: Piperazine, 1-(3-phenylpropyl)-4-((2-(3-pyridinyl)-4-thiazolidinyl)carbonyl)-, (E)-2-butenedioate (1:1), YM-461, YM461 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyridinesThiazolidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF…
The metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 was investigated, and their metabolites were compared… 
1998
1998
2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. II. Structure-activity relationships and active configuration of 2-(3-pyridyl)thiazolidine-4-carboxamides as platelet-activating factor receptor…
Conversion of the 2-(3-pyridyl)thiazolidine part of 1-(3-phenylpropyl)-4-[2-(3-pyridyl)thiazolidine-4-carbonyl]piperazine (YM461… 
1991
1991
Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist
The antagonistic effect of YM461 [1-(3-phenylpropyl)-4-[2-(3-pyridyl)thiazolidin-4-ylcarbonyl]piperazine fumarate] against… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)